Increased sensitivity to N-methyl-D-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice

Journal of Neuroimmunology

Volumn 133, Issue 1-2, 2002, Pages 108-115

  Pelidou, Sigliti Henrietta ^a   Schultzberg, Marianne ^b   Iverfeldt, Kerstin ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokine; Glutamate receptor; Knock out; Neuronal cell death; Primary neuronal cultures

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DIZOCILPINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL STIMULATION; CELL SURVIVAL; CEREBELLUM; CONTROLLED STUDY; CYTOTOXICITY; GRANULE CELL; KNOCKOUT MOUSE; MOUSE; NEUROTOXICITY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036890031     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00369-7     Document Type: Article

References (67)

1. 12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur. J. Pharmacol. 241:1993;1-6.
2. Ankarcrona M., Dypbukt J., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis dependent on mitochondrial function. Neuron. 15:1995;961-973.
3. Ankarcrona M., Dypbukt J., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394:1996;321-324.
4. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience. 43:1991;21-30.
5. Bandtlow C.E., Meyer M., Lindholm D., Spranger M., Heumann R., Thoenen H. Regional and cellular codistribution of interleukin 1b and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J. Cell Biol. 111:1990;1701-1711.
6. +-induced depolarization and NMDA treatment. Neuron. 12:1994;87-95.
7. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 240:1988;321-324.
8. Brenneman D.E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
9. Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., Gahring L.C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163:1999;3963-3968.
10. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9:1995;355-365.
11. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
12. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100:1994;47-51.
13. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
14. Cunningham E.T. Jr., Wada E., Carter D.B., Tracey D.E., Battey J.F., De Souza E.B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J. Neurosci. 12:1992;1101-1114.
15. De Bock F., Dornand J., Rondouin G. Release of TNF-α in the hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport. 7:1996;1125-1129.
16. Diana A., van Dam A.-M., Winblad B., Schultzberg M. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience. 89:1999;137-147.
17. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
18. Dux E., Oschlies U., Wiessner C., Hossmann K.A. Glutamate-induced ribosomal dissaggregation and ultrastructural changes in rat cortical culture - protective effect of horse serum. Neurosci. Lett. 141:1992;173-176.
19. Erbö S.L., Michler A., Wolff J.R., Tytko H. Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex. Brain Res. 526:1990;328-332.
20. Eriksson G., Zetterström M., Cortes Toro V., Bartfai T., Iverfeldt K. Hypersensitive cytokine response to β-amyloid 25-35 in astroglial cells from IL-1 type I-deficient mice. Int. J. Mol. Med. 1:1998;201-206.
21. Eriksson C., Van Dam A.-M., Lucassen P.J., Bol J.G.J.M., Winblad B., Schultzberg M. Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience. 93:1999;915-930.
22. Farrar W.L., Kilian P.L., Ruff M.R., Hill J.M., Pert C.B. Visualization and characterization of interleukin 1 receptors in brain. J. Immunol. 139:1987;459-463.
23. Frandsen A., Schousboe A. Development of excitatory amino acid induced cytotoxicity in cultured neurons. Int. J. Dev. Neurosci. 8:1990;209-216.
24. Frandsen A., Drejer J., Schousboe A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors. J. Neurochem. 53:1989;297-299.
25. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., Bluthe R.M., Keith W.K. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J. Neuroimmunol. 93:1999;194-202.
26. Gallo V., Kingsbury A., Balazs R., Jorgensen O.S. The role of depolarization in the survival of cerebellar granule cells in culture. J. Neurosci. 7:1987;2203-2213.
27. Gao Y., Ng Y.K., Lin J.Y., Ling E.A. Expression of immunoregulatory cytokines in neurons of the lateral hypothalamic area and amygdaloid nuclear complex of rats immunized against human IgG. Brain Res. 859:2000;364-368.
28. Garthwaite G., Garthwaite J. In vitro neurotoxicity of excitatory amino acid analogues during cerebellar development. Neuroscience. 17:1986;755-767.
29. Giulian D., Baker T.J., Shih L.C., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
30. Glaccum M.B., Stocking K.L., Charrier K., Smith J.L., Willis C.R., Maliszewski C., Livingston D.J., Peschon J.J., Morrissey P.J. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159:1997;3364-3371.
31. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7611-7615.
32. Guerrini L., Blasi F., Dennis-Donini S. Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9077-9081.
33. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
34. Huck S. Serum-free medium for cultures of the postnatal mouse cerebellum: only insulin is essential. Brain Res. Bull. 10:1983;667-674.
35. Huitinga I., van der Cammen M., Salm L., Erkut Z., van Dam A.-M., Tilders F., Swaab D. IL-1β immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis. J. Neuroimmunol. 107:2000;8-20.
36. Ishii K., Katayama M., Hori K., Yodoi J., Nakanishi T. Effects of 2-Mercaptoethanol on survival and differentiation of fetal mouse brain neurons cultured in vitro. Neurosci. Lett. 163:1993;159-162.
37. Jacobs C.A., Baker P.E., Roux E.R., Picha K.S., Toivola B., Waugh S., Kennedy M.K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146:1991;2983-2989.
38. Kusumoto M., Dux E., Hossmann K.A. Effect of trophic factors on delayed neuronal death induced by in vitro ischemia in cultivated hippocampal and cortical neurons. Metab. Brain Dis. 12:1997;113-120.
39. Labow M., Shuster D., Zetterström M., Nunes P., Terry R., Cullinan E.B., Bartfai T., Solorzano C., Moldawer L.L., Chizzonite R., McIntyre K.W. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:1997;2452-2461.
40. Lafon-Cazal M., Culcasi M., Gaven F., Pietri S., Bockaert J. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology. 32:1993;1259-1266.
41. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16:1996;932-940.
42. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1β promotes repair of the CNS. J. Neurosci. 21:2001;7046-7052.
43. Massieu L., Morales-Villagran A., Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vitro microdialysis study. J. Neurochem. 64:1995;2262-2272.
44. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative diseases. Trends Pharmacol. Sci. 11:1990;379-386.
45. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Convulsants induce interleukin-1β messenger RNA in rat brain. Biochem. Biophys. Res. Commun. 171:1990;832-837.
46. Molenaar G.J., Berkenbosch F., van Dam A.M., Lugard C.M. Distribution of interleukin 1 beta immunoreactivity within the porcine hypothalamus. Brain Res. 608:1993;169-174.
47. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
48. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1615.
49. Olney J.W., Wozniak D.F., Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease. Arch. Neurol. 54:1997;1234-1240.
50. Parnet P., Amindari S., Brunke-Reese D.L., Goujon E., Weyhenmeyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in the mouse brain. Brain Res. Mol. Brain Res. 27:1994;63-70.
51. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1RacP. J. Biol. Chem. 271:1996;3967-3970.
52. Patel J., Zinkand W.C., Thompson C., Keith R., Salama A. Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J. Neurochem. 54:1990;849-854.
53. Pizzi M., Goffi F., Boroni F., Benarese M., Perkins S.E., Liou H.-C., Spano P. Opposing roles for NF-κB/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1β J. Biol. Chem. 277:2002;20717-20723.
54. Resink A., Hack N., Boer G.J., Balazs R. Growth conditions differentially modulate the vulnerability of developing cerebellar granule cell to excitatory amino acids. Brain Res. 655:1994;222-232.
55. +-induced depolarization and NMDA exposure. J. Neurochem. 64:1995;558-565.
56. Rothwell N.J., Allan S., Toulmond S. The role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652.
57. Schousboe A., Drejer J., Hansen G., Meier E. Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids. Dev. Neurosci. 7:1985;252-262.
58. Schramm M., Eimeri S., Costa E. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells. Role of the glutamate receptor responsive to N-methyl-D-aspartate. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1193-1197.
59. Sims J.E., Dower S.K. Interleukin-1 receptors. Eur. Cytokine Netw. 5:1994;539-546.
60. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Näher-Noé M., Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the central nervous system: comparison between the effects of interleukin-1β and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:1990;69-76.
61. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:1995;3468-3474.
62. Takao T., Tracey D.E., Mitchell W.M., De Souza E.B. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology. 127:1990;3070-3078.
63. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma. 19:2002;939-951.
64. Thorns V., Walter G.F., Licastro F. Effects of IL6 and IL1β on a FGF expression and excitotoxicity in NT2N cells. J. Neuroimmunol. 127:2002;22-29.
65. van Dam A.M., Brouns M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588:1992;291-296.
66. Watt J.A., Hobbs N.K. Interleukin-1 beta immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: evidence for activity-dependent release. J. Neurosci. Res. 60:2000;478-489.
67. Yu A.C.H., Hertz E., Hertz L. Alterations in uptake and release rates for GABA, glutamate and glutamine during biochemical maturation of highly purified cultures of cerebral cortical neurons, a GABAergic preparation. J. Neurochem. 42:1984;951-960.